secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oscar Health, Inc. (OSCR)
CIK:        0001568651
Form:       8-K
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0001193125-24-005574
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Oscar Health reaffirms FY2023 guidance and 2024 EBITDA target; no new figures
-----------------------------------------------------------------------------

- Reaffirms full year 2023 guidance as provided in Q3 2023 earnings release (Nov 7, 2023).
- Reaffirms target for Total Company Adjusted EBITDA profitability in 2024.
- To provide interim membership update from 2024 open enrollment at JPM conference.
- No specific financial results or new numbers disclosed in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1568651/000119312524005574/0001193125-24-005574-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1568651/000119312524005574/d581645d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-005574

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer